Benzinga | Sep 17, 2020 04:02PM EDT

Acutus Medical Announces FDA Clearance Of AcQMap 3D Imaging & Mapping Catheter

CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (NASDAQ:AFIB) today announces FDA 510(k) clearance of the second-generation AcQMap(r) 3D imaging and mapping catheter which builds on its predecessor, improving handling and deliverability. This flagship 3D mapping and navigation catheter combines 48 ultrasound transducers responsible for creating the anatomical geometry and 48 engineered electrodes which enable electrical activation patterns to be displayed along the inner surface of the heart. Compatible with an 0.035" guidewire, the AcQMap catheter is designed to be inserted into the left and right atrium.